Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16
Open Access
- 1 December 1988
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (6) , 576-578
- https://doi.org/10.1038/bjc.1988.131
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Occurrence of a multidrug-resistant phenotype in human lung xenograftsBritish Journal of Cancer, 1987
- Phase I study of vinblastine and verapamil given by concurrent iv infusion.1985
- EFFECTS OF VERAPAMIL ON ETOPOSIDE, VINCRISTINE, AND ADRIAMYCIN ACTIVITY IN NORMAL HUMAN-BONE MARROW GRANULOCYTE-MACROPHAGE PROGENITORS AND IN HUMAN K562 LEUKEMIA-CELLS INVITRO1985
- Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cellsBritish Journal of Cancer, 1984
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- POTENTIATION OF ETOPOSIDE-INDUCED DNA DAMAGE BY CALCIUM-ANTAGONISTS IN L1210 CELLS-INVITRO1984
- POTENTIATION OF VINCRISTINE AND ADRIAMYCIN EFFECTS IN HUMAN HEMATOPOIETIC TUMOR-CELL LINES BY CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1983
- PROMOTION BY VERAPAMIL OF VINCRISTINE RESPONSIVENESS IN TUMOR-CELL LINES INHERENTLY RESISTANT TO THE DRUG1983
- Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites CarcinomaJournal of Clinical Investigation, 1982
- OVERCOMING OF VINCRISTINE RESISTANCE IN P388 LEUKEMIA INVIVO AND INVITRO THROUGH ENHANCED CYTO-TOXICITY OF VINCRISTINE AND VINBLASTINE BY VERAPAMIL1981